Pralym^®

Pralatrexate

Product Information

Proprietary Name: Pralym®
Generic Name: Pralatrexate
Dosage Form: Vial
Strengths: 20 mg/1 ml
Indications: Peripheral T-cell Lymphoma (PTCL)

Download Leaflet

Oncology

Pralym®

Pralatrexate is indicated for the treatment of peripheral T-cell lymphoma (PTCL).

Apply for a Job Position

Curious about job opportunities?

Signup for a job

Products

Support

Company

Follow Us

© NanoAlvand. All rights reserved. Powered by ِDGN.